Cryofocus Medtech (Shanghai) Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sinco Pharmaceuticals Holdings Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Pioneer Holding Ltd.

IVD Medical Holding Ltd.

Meilleure Health International Industry Group Ltd.

China Health Group Ltd.

Cryofocus Medtech (Shanghai) Co. Ltd.

Tycoon Group Holdings Ltd.

Kingworld Medicines Group Ltd.

Yestar Healthcare Holdings Co. Ltd.

Guanze Medical Information Industry (Holding) Co., Ltd.

Why is Cryofocus Medtech (Shanghai) Co. Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -125.74

Flat results in Jun 25

RAW MATERIAL COST(Y) Grown by 12.56% (YoY)
INTEREST(Q) Highest at HKD 1.13 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -14.47%, its profits have risen by 27.8%

Underperformed the market in the last 1 year

Even though the market (Hang Seng Hong Kong) has generated returns of 27.36% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -14.47% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cryofocus Medtech (Shanghai) Co. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cryofocus Medtech (Shanghai) Co. Ltd.

-14.47%

-0.18

72.46%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

50.98%

EBIT Growth (5y)

9.02%

EBIT to Interest (avg)

-125.74

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.13

Sales to Capital Employed (avg)

2.10

Tax Ratio

0.12%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

11.43

EV to EBIT

-6.45

EV to EBITDA

-7.25

EV to Capital Employed

23.26

EV to Sales

7.48

PEG Ratio

Dividend Yield

ROCE (Latest)

-360.54%

ROE (Latest)

-141.62%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 1.16%

NET SALES(Q)

Highest at HKD 54.9 MM

OPERATING PROFIT(Q)

Highest at HKD -23.36 MM

OPERATING PROFIT MARGIN(Q)

Highest at -42.54 %

PRE-TAX PROFIT(Q)

Highest at HKD -29.23 MM

NET PROFIT(Q)

Highest at HKD -25.58 MM

EPS(Q)

Highest at HKD -0.11

-7What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 12.56% (YoY

INTEREST(Q)

Highest at HKD 1.13 MM

Here's what is working for Cryofocus Medtech (Shanghai) Co. Ltd.

Net Sales

At HKD 54.9 MM has Grown at 160.12%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely positive

Net Sales (HKD MM)

Net Sales

Highest at HKD 54.9 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD -23.36 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at -42.54 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD -29.23 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Pre-Tax Profit

At HKD -29.23 MM has Grown at 51.79%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD -25.58 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

Net Profit

At HKD -25.58 MM has Grown at 54.75%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD -0.11

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Inventory Turnover Ratio

Highest at 1.16%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Cryofocus Medtech (Shanghai) Co. Ltd.

Interest

Highest at HKD 1.13 MM

in the last five periods and Increased by 59.97% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Raw Material Cost

Grown by 12.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales